Correction: Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo (PLoS ONE (2013) 8, 2 (e55620) DOI: 10.1371/journal.pone.0055620);Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Becker, Svetlana ^a,b   Oelschlaeger, Tobias A ^c   Wullaert, Andy ^d   Pasparakis, Manolis ^d,e   Wehkamp, Jan ^a,b,f   Stange, Eduard F ^f   Gersemann, Michael ^a,b,f  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^f ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; DEFENSIN HBD2; FLAGELLIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MUCIN 1; MUCIN 2; PROBIOTIC AGENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HATH1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; CELL COUNT; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; COLON FLORA; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI K 12; ESCHERICHIA COLI NISSLE 1917; GENE EXPRESSION; GOBLET CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; LACTOBACILLUS; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84873911271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/13f3d7ee-a72c-4879-bedb-8e73b6b364ac     Document Type: Erratum

References (67)

1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
2. Ley RE, Peterson DA, Gordon JI, (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
3. Sears CL, (2005) A dynamic partnership: celebrating our gut flora. Anaerobe 11: 247-251.
4. Shirazi T, Longman RJ, Corfield AP, Probert CS, (2000) Mucins and inflammatory bowel disease. Postgrad Med J 76: 473-478.
5. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, et al. (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113-118.
6. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102: 18129-18134.
7. Wehkamp J, Schmid M, Stange EF, (2007) Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 23: 370-378.
8. Zhao C, Wang I, Lehrer RI, (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 396: 319-322.
9. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, et al. (2008) Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57: 764-771.
10. Crosnier C, Stamataki D, Lewis J, (2006) Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet 7: 349-359.
11. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY, (2001) Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294: 2155-2158.
12. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, et al. (2000) Control of endodermal endocrine development by Hes-1. Nat Genet 24: 36-44.
13. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129: 2619-2628.
14. Gersemann M, Stange EF, Wehkamp J, (2003) From intestinal stem cells to inflammatory bowel diseases. World J Gastroenterol 17: 3198-3203.
15. Gersemann M, Wehkamp J, Fellermann K, Stange EF, (2008) Crohn's disease-defect in innate defence. World J Gastroenterol 14: 5499-5503.
16. Sartor RB, (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
17. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127: 412-421.
18. Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, et al. (2006) Comparative study of the intestinal mucous barrier in normal and inflamed colon. Gut 56(3): 343-350.
19. Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, et al. (2007) The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 179: 3109-3118.
20. Koslowski MJ, Kubler I, Chamaillard M, Schaeffeler E, Reinisch W, et al. (2009) Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS ONE 4: e4496.
21. Gersemann M, Becker S, Kubler I, Koslowski M, Wang G, et al. (2009) Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 77: 84-94.
22. Zheng X, Tsuchiya K, Okamoto R, Iwasaki M, Kano Y, et al. (2011) Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm Bowel Dis 17: 2251-2260.
23. McCormick DA, Horton LW, Mee AS, (1990) Mucin depletion in inflammatory bowel disease. J Clin Pathol 43: 143-146.
24. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, et al. (1994) Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35: 353-359.
25. Biarc J, Nguyen IS, Pini A, Gosse F, Richert S, et al. (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis 25: 1477-1484.
26. Newman JV, Kosaka T, Sheppard BJ, Fox JG, Schauer DB, (2001) Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 184: 227-230.
27. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, et al. (1998) Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115: 281-286.
28. Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori T, Abubaker F, (2009) Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 9: 403.
29. Gupta A, Madani R, Mukhtar H, (2010) Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis 12: 164-171.
30. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, et al. (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72: 5750-5758.
31. Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, et al. (2003) Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 9: 215-223.
32. Stoscheck CM, (1990) Quantitation of protein. Methods Enzymol 182: 50-68.
33. Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, et al. (2007) Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukoc Biol doi: 10.1189/jlb.0906581.
34. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, et al. (2007) The Induction of Human Beta-Defensin-2 by the Probiotic Escherichia coli Nissle 1917 is Mediated through Flagellin. Infect Immun 75(5): 2399-407.
35. Xing Q, Ye Q, Fan M, Zhou Y, Xu Q, et al. (2010) Porphyromonas gingivalis lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activating Notch1 signaling. J Cell Physiol 225: 106-114.
36. Kapoor N, Narayana Y, Patil SA, Balaji KN, (2010) Nitric oxide is involved in Mycobacterium bovis bacillus Calmette-Guerin-activated Jagged1 and Notch1 signaling. J Immunol 184: 3117-3126.
37. Park JH, Kim HJ, Choy HE, Kim K, (2005) Presence of presenilin 1/2 affects the invasion and replication of Salmonella typhimurium. Biochem Biophys Res Commun 332: 1081-1085.
38. Zhou Q, Amar S, (2007) Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J Immunol 179: 7777-7790.
39. Otte JM, Podolsky DK, (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286: G613-G626.
40. Caballero-Franco C, Keller K, De SC, Chadee K, (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292: G315-G322.
41. Kim Y, Kim SH, Whang KY, Kim YJ, Oh S, (2008) Inhibition of Escherichia coli O157: H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J Microbiol Biotechnol 18: 1278-1285.
42. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA, (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52: 827-833.
43. Croix JA, Bhatia S, Gaskins HR, (2011) Inflammatory cues modulate the expression of secretory product genes, Golgi sulfotransferases and sulfomucin production in LS174T cells. Exp Biol Med (Maywood) 236: 1402-1412.
44. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML, (2003) Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 131: 90-101.
45. Gersemann M, Wehkamp J, Stange E, (2011) Innate immune dysfunction in inflammatory bowel disease. J Intern Med 271: 421-428.
46. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, et al. (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231.
47. D'Haens G, Geboes K, Peeters M, Baert F, Penninckx F, et al. (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262-267.
48. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53: 1658-1664.
49. Hugot J-P, Chamaillard C, Zouali H, Lesage S, Cezard J-P, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
50. Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, et al. (2007) Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 56: 1536-1542.
51. Cario E, (2010) Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 16: 1583-1597.
52. Lucke K, Miehlke S, Jacobs E, Schuppler M, (2006) Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 55: 617-624.
53. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ, (2006) Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 44: 4136-4141.
54. Fyderek K, Strus M, Kowalska-Duplaga K, Gosiewski T, Wedrychowicz A, et al. (2009) Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol 15: 5287-5294.
55. Obata Y, Takahashi D, Ebisawa M, Kakiguchi K, Yonemura S, et al. (2012) Epithelial cell-intrinsic notch signaling plays an essential role in the maintenance of gut immune homeostasis. J Immunol 188: 2427-2436.
56. Marteau P, Chaput U, (2011) Bacteria as trigger for chronic gastrointestinal disorders. Dig Dis 29: 166-171.
57. Cover TL, Blaser MJ, (2009) Helicobacter pylori in health and disease. Gastroenterology 136: 1863-1873.
58. Biarc J, Nguyen IS, Pini A, Gosse F, Richert S, et al. (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis 25: 1477-1484.
59. Abdulamir AS, Hafidh RR, Abu BF, (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res 30: 11.
60. Chen CC, Lin WC, Kong MS, Shi HN, Walker WA, et al. (2011) Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue. Br J Nutr 1-12.
61. Liong MT, (2008) Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci 9: 854-863.
62. Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, et al. (2008) Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 33: 1223-1229.
63. Peignon G, Durand A, Cacheux W, Ayrault O, Terris B, et al. (2011) Complex interplay between beta-catenin signalling and Notch effectors in intestinal tumorigenesis. Gut 60: 166-176.
64. Park ET, Oh HK, Gum JR Jr, Crawley SC, Kakar S, et al. (2006) HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res 12: 5403-5410.
65. Leow CC, Romero MS, Ross S, Polakis P, Gao WQ, (2004) Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 64: 6050-6057.
66. Evans PM, Liu C, (2008) Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 40: 554-564.
67. Zhang W, Chen X, Kato Y, Evans PM, Yuan S, et al. (2006) Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 26: 2055-2064.